[1] 中华医学会传染病与寄生虫病学分会和肝病分会. 病毒性肝炎防治方案[J]. 中华肝脏病杂志,2000,8(6):324-329. [2] 仲剑平. 医疗护理技术操作常规[M]. 4版,人民军医出版社,1998:120. [3] ZHANG Z,ZHANG JY,WHERRY EJ,et al. Dynamin programmed death 1 expression by virus-specfic CD8 T cells correlates with the outcome of acute hepatitis B[J]. Gastroenterology,2008,134:1938-1949. [4] GUIDOTTI LG,ROCHFORD R,CHUNG J,et al. Viral clearance without destruction of infected cells during acute HBV infection[J]. Science,1999,284:825-829. [5] GUIDOTTI LG,LSHIKAWA T,HOBBS MV,et al. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes[J]. Immunity,1996,4:25-36. [6] THIMME R,WIELAND S,STEIGER C,et al. CD8 + T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection[J]. J Virol,2003,77:68-76. [7] MAINIMK,REIGNAT S,BONI C,et al. T cell receptor usage of virus specific CD8 cells and recognition of viral mutations during acute and persistent hepatitis B virus infection[J]. Eur J Immunol,2000,30:3067-3078. [8] HU KQ. Occult hepatitis B virus infection and its clinical implication[J]. J Viral Hepat,2002,9:243-257. [9] 骆抗先. 乙型肝炎基础和临床[M]. 2版,北京:人民卫生出版社,2001:327. |